Insider · CIK 0001284621

OTTO MICHAEL J.

Reports to the SEC for 2 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001284621

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-05-17	CONTRAFECT CorpOptions (Right to Buy)A Award	Director	AAward	+42K sh	$3.35	+$141K	42,000
2021-05-18	CONTRAFECT CorpOptions (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-07-25	CONTRAFECT CorpP Purchase	Director	PPurchase	+8,000 sh	$1.24	+$9,920	8,000
2017-07-25	CONTRAFECT CorpWarrants (Right to Buy)P Purchase	Director	PPurchase	+4,000 sh	$0.01	+$40	4,000
2012-01-12	Pharmasset IncU Disposition from Tender	Chief Scientific Officer	UDisposition from Tender	−14.4K sh	$137.00	−$1.97M	0
2012-01-12	Pharmasset IncStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−0.67 sh	—	—	0
2012-01-12	Pharmasset IncStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−10K sh	—	—	0
2012-01-12	Pharmasset IncStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−27.4K sh	—	—	0
2012-01-12	Pharmasset IncStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−12.1K sh	—	—	0
2012-01-12	Pharmasset IncStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−22.5K sh	—	—	0
2012-01-12	Pharmasset IncStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−50K sh	—	—	0
2012-01-12	Pharmasset IncStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−60K sh	—	—	0
2011-11-01	Pharmasset IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+17.5K sh	$10.83	+$190K	17,500
2011-11-01	Pharmasset IncS Sale	Chief Scientific Officer	SSale	−17.5K sh	$74.56	−$1.3M	0
2011-11-01	Pharmasset IncStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−17.5K sh	—	—	0
2011-10-11	Pharmasset IncStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+60K sh	—	—	60,000
2011-08-01	Pharmasset IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+8,929 sh	$18.60	+$166K	16,118
2011-08-01	Pharmasset IncS Sale	Chief Scientific Officer	SSale	−8,929 sh	$119.99	−$1.07M	7,189
2011-08-01	Pharmasset IncStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−8,929 sh	—	—	6,071
2011-04-28	Pharmasset IncS Sale	Chief Scientific Officer	SSale	−9,500 sh	$99.85	−$949K	7,189
2011-03-22	Pharmasset IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+6,279 sh	$13.67	+$85.8K	22,968
2011-03-22	Pharmasset IncS Sale	Chief Scientific Officer	SSale	−6,279 sh	$64.00	−$402K	16,689
2011-03-22	Pharmasset IncStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,279 sh	—	—	13,721
2010-10-14	Pharmasset IncStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+25K sh	—	—	25,000
2010-10-01	Pharmasset IncS Sale	Chief Scientific Officer	SSale	−5,000 sh	$29.50	−$148K	16,689
2010-09-28	Pharmasset IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+7,811 sh	$4.02	+$31.4K	34,500
2010-09-28	Pharmasset IncS Sale	Chief Scientific Officer	SSale	−12.8K sh	$29.50	−$378K	21,689
2010-09-28	Pharmasset IncStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−7,811 sh	—	—	5,000
2010-07-01	Pharmasset IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+7,189 sh	$4.02	+$28.9K	26,689
2010-07-01	Pharmasset IncStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−7,189 sh	—	—	12,811
2009-10-14	Pharmasset IncStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+20K sh	—	—	20,000
2009-09-18	Pharmasset IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+40K sh	$3.87	+$155K	59,500
2009-09-18	Pharmasset IncS Sale	Chief Scientific Officer	SSale	−13.4K sh	$21.90	−$293K	46,100
2009-09-18	Pharmasset IncS Sale	Chief Scientific Officer	SSale	−9,300 sh	$21.92	−$204K	36,800
2009-09-18	Pharmasset IncS Sale	Chief Scientific Officer	SSale	−8,200 sh	$21.94	−$180K	28,600
2009-09-18	Pharmasset IncS Sale	Chief Scientific Officer	SSale	−4,500 sh	$21.95	−$98.8K	2,410
2009-09-18	Pharmasset IncS Sale	Chief Scientific Officer	SSale	−4,600 sh	$21.97	−$101K	19,500
2009-09-18	Pharmasset IncStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−40K sh	—	—	0
2007-10-10	Pharmasset IncStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+15K sh	—	—	15,000
2007-10-10	Pharmasset IncStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+20K sh	—	—	20,000
2007-09-05	Pharmasset IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10K sh	$3.00	+$30K	19,500
2007-09-05	Pharmasset IncStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10K sh	—	—	83,333

Recent filings

Accepted (ET)
May 184
OTTO MICHAEL J.0001209191-22-030271
SEC(opens sec.gov)
May 204
OTTO MICHAEL J.0001209191-21-034735
SEC(opens sec.gov)
Jul 264
OTTO MICHAEL J.0001209191-17-046317
SEC(opens sec.gov)
Jan 174
OTTO MICHAEL J.0001209191-12-003881
SEC(opens sec.gov)
Nov 74
OTTO MICHAEL J.0001209191-11-054808
SEC(opens sec.gov)
Oct 134
OTTO MICHAEL J.0001209191-11-051684
SEC(opens sec.gov)
Aug 34
OTTO MICHAEL J.0001192482-11-000194
SEC(opens sec.gov)
Apr 294
OTTO MICHAEL J.0001192482-11-000109
SEC(opens sec.gov)

Companies

Address

303A COLLEGE ROAD EAST

PRINCETON, NJ, 08540